4//SEC Filing
Liu Dongfang 4
Accession 0001937915-25-000006
CIK 0001811063other
Filed
Nov 23, 7:00 PM ET
Accepted
Nov 24, 4:08 PM ET
Size
9.0 KB
Accession
0001937915-25-000006
Insider Transaction Report
Form 4
Liu Dongfang
CHIEF MEDICAL OFFICER
Transactions
- Exercise/Conversion
Class A Common Stock
2025-11-20$1.87/sh+20,000$37,400→ 38,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-11-20−20,000→ 450,000 totalExercise: $1.87Exp: 2034-02-27→ Class A Common Stock (20,000 underlying) - Sale
Class A Common Stock
2025-11-20$7.00/sh−20,000$140,074→ 18,000 total
Footnotes (2)
- [F1]Price reported is a weighted-average sales price. The shares were sold at prices ranging from $7.00 to $7.005. The Reporting Person will provide, upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- [F2]Option vested as to 25% on the one year anniversary of 2/29/2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.
Documents
Issuer
Nuvation Bio Inc.
CIK 0001811063
Entity typeother
Related Parties
1- filerCIK 0001937915
Filing Metadata
- Form type
- 4
- Filed
- Nov 23, 7:00 PM ET
- Accepted
- Nov 24, 4:08 PM ET
- Size
- 9.0 KB